Fair Value Calculator Fair Value Calculator
EN DE

SUMUKA (SUMUKA) Fair Value & Analysis

IN · Market cap ₹3.7B

S SUMUKA SUMUKA · BSE
Price₹126.55
Fair Value₹45.42
Upside-64.1%
Quality42/100
Watch SUMUKA for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹33.33 – ₹57.51

Fair value as of: Jul 6, 2026

From 15 valuation models · updated yesterday

Share price −11.0% over the past month.

Price vs Fair Value (12 months)

₹256.65 ₹117.55 Fair Value ₹45.42 Jul 2025 Jul 2026

12‑month range ₹117.55 – ₹256.65 · fair‑value band ₹33.33 – ₹57.51 · the ₹126.55 price screens above the ₹45.42 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

SUMUKA (SUMUKA) currently trades at ₹126.55, while our model-based Fair Value estimate is ₹45.42 — implying the stock looks roughly 64.1% overvalued today. We read business quality at 42/100 (below-average quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, SUMUKA generated revenue of ₹793M at a net margin of 3.8%. Revenue grew 24.4% year over year. It earns a return on equity of 15.1%. Net debt stands at ₹61.4M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹33.33 (bear case) to ₹57.51 (bull case); at ₹126.55, the current price sits above that range. The share trades about 53% below its 52-week high and 25% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹793M
Revenue growth (YoY) +24.4%
Net margin 3.8%
Return on equity 15.1%
Free cash flow −₹5.0M FY2026
P/E ratio 70.4
More key figures
Operating margin 4.1%
EPS (TTM) ₹2.48
EPS growth (YoY) +8.0%
Net debt ₹61.4M FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

SUMUKA reported revenue of ₹1.3B in FY2026 versus ₹13.9M in FY2022, a compound +209.3%/yr. Reported net income was ₹51.8M in FY2026, compounding +116.5%/yr from FY2022.

Revenue +209.3%/yr
FY22 ₹13.9M
FY23 ₹279M
FY24 ₹550M
FY25 ₹977M
FY26 ₹1.3B
Net income +116.5%/yr
FY22 ₹2.4M
FY23 ₹23.2M
FY24 ₹42.6M
FY25 ₹46.8M
FY26 ₹51.8M

Is SUMUKA fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "SUMUKA Fair Value". https://www.fairvalue-calculator.com/stock/SUMUKA

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is SUMUKA (SUMUKA) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹45.42 versus a price of ₹126.55 — about −64% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SUMUKA?
Our model-based fair value for SUMUKA is ₹45.42 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹126.55.
What is the quality score of SUMUKA?
SUMUKA has a Quality Score of 42/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of SUMUKA (SUMUKA)?
SUMUKA reported trailing-twelve-month revenue of about ₹793M (latest available figure, as of Jul 6, 2026).
What is the net profit margin of SUMUKA?
The net profit margin of SUMUKA is about 3.8%, meaning it keeps roughly 3.8% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.